JNJ trade ideas
JOHNSON & JOHNSON D1 VACCINE FOR CORONO VIRUSJohnson & Johnson pioneered and tested the Corono Virus vaccine. The monkeys received the first vaccines. Six and six monkeys received protection for their lungs. And five individuals began to develop antibodies. The US government has committed $ 456 million to accelerate vaccine development. In the near future, this vaccine will be tested in humans. America is now the epicenter of the epidemic. And the government is doing everything it can to save the violence, preventing mass deaths. Although with the current situation in the United States, it is very difficult to succeed. But if the company does everything to bring its experiment to the desired effect. This will help her make a fortune. And against the backdrop of such prospects, the stock will certainly rise rapidly.
Johnson & Johnson D1Following encouraging results from Johnson & Johnson's experimental vaccine test in monkeys showing that a single dose is sufficient to protect them from the coronavirus, the final human trial of the vaccine began in the United States on Thursday.
The test results were published in the scientific journal Nature, and according to the article, 6 out of 6 monkeys who were injected with the vaccine received full protection against lung disease, and 5 out of 6 also developed antibodies that protect against coronavirus infection.
Dr. Paul Stoffels, chief scientist at J&J, said it would be possible to test a single dose of the vaccine in humans and see if it has a protective effect against the virus. Stoffels believes that a single dose of the vaccine has a significant advantage in eliminating the logistical cost of getting people back to the clinic to re-administer the vaccine.
J&J has received government aid in the amount of $ 456 million in a government program aimed at accelerating the production of a vaccine to combat the coronavirus pandemic. The company plans to begin a large-scale third phase with a single dose of vaccine in the second half of September. A study with two doses of vaccine will begin around the same time. If the company nevertheless brings the experiment to its logical conclusion, this device may become a gold mine for it. And the company's capitalization will skyrocket just like the stock price.
JnJ continues upward trendHey everyone,
I think JnJ will turn back upwards near the arrows, which means right away or at the 50/61 Retracement, but please wait for confirmation signals.
Chickou Span crosses the stock, which is negative, Tenkan-Sen is above Kijun-Sen, which is good and the cloud is rising, which is good too.
As i said, you should wait for a reversal confirmation, than my regular goal would be 162 USD.
Much fun with that trade!
Leave a follow :)
waiting for entryRecent bullish breakout met with resistance at 151.82
broke 9ema
support at 20sma
expecting retest the bearish channel before continuing bullish move
entry 140.70
stop loss 137.50
target 155.94
$JNJ Johnson & Johnson Trade setup
Potential run back to the highs, setting up a potential break to all time highs.
Highly diversified and has got a Covid vaccine in its armor.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
JNJ next week !I advais you to not buy now , the time is for selling
wait my signal for BUYING (tell me )
JNJJohnson & Johnson (JNJ) | Market Cap: $393bn | Sector: Pharmaceuticals
After a 3-month consolidation, the stock broke out of a bull flag technical formation where a measured target is ~ $185.
Despite a weak earnings J&J seems to be breaking out The bear swing we saw in the last moth seems give place to a more bullish take over. Despite weak ernings
JNJ IH&S Neckline PushJNJ is looking healthy to push higher. The 8dma/50dma crossed today, a historically good sign for JNJ. There seems to be an IH&S forming on the daily, with JNJ nearing neckline level at 150. The MACD is beginning to converge quickly as well. With the recent ER beat, looks good to make new highs.
JNJ 157price target still the same. after a couple more candles looks like an inverse head and shoulders. already in a call. we shall see how earnings play out :)
Johnson & Johnson Earnings Estimates Q2 2020$JNJ reports earnings 07/16/2020
The above chart consists of earnings estimates (source: Yahoo Finance Premium) and a technical analysis.
Johnson & Johnson Looking for the next bull move Hi traders:
JNJ, is shaping up to a great opportunities for long.
We have price impulse to the upside, and now forming a nice correction structure channel.
I am patiently waiting for the last bit of price action to complete to give me extra confluence on a long.
I would like to see price correctively go lower once more and complete the smaller structure within the larger correction.
That would give me the best Risk/Reward to go long to the recent tops.
Alternatively, if price begin its bull run form here, then I would wait for breakout of this larger structure and look for continuation correction in the lower time frame.
Thank you
Johnson & Johnson Will FallJNJ has, like many of the individual stocks I have recently covered, also formed a long-term rising broadening pattern. But whereas with, say, Amazon, which is at the top of its broadening pattern's range, Johnson & Johnson looks to have completed that last stop in January of 2018.
After the final touch on the bottom, in this case March of this year, the price action generally follows the arc.
Johnson & Johnson Quietly Basing for ATH MoveTarget annotated in the chart. May take a few weeks, but looks strong.
PT still 157 JNJ is next. Entered this at .59. Down 8$. Should have a nice run up during the week for running. The good thing is that the call is for 7/24 so theta won't crush us. PT is 157. Closed above the resistance and looks like it's ready to break out of its down trend. Will sell for profit Wednesday. Don’t want to hold through earnings.
